VIVEbiotech Appoints Patricio Massera as President
VIVEbiotech
Patricio Massera
San Sebastián, Gipuzkoa, Spain, July 03, 2025 (GLOBE NEWSWIRE) -- VIVEbiotech, a leading Contract Development and Manufacturing Organization (CDMO) specializing in lentiviral vector (LVV) development and manufacturing for in vivo and ex vivo gene and cell therapies, today announced the appointment of Patricio Massera as President, in addition to his role on the VIVEbiotech Board of Directors.
The appointment marks a significant step in VIVEbiotech's strategy to scale its capabilities, expand globally, and enhance operational quality and excellence following a recent growth investment from Ampersand Capital Partners, a life sciences and healthcare-focused private equity firm.
Mr. Massera has over 25 years of leadership experience in the biopharmaceutical CDMO sector. Most recently, he served as CEO of AGC Biologics, where he led the company through global facility expansions and advanced its reputation for quality, innovation, and customer satisfaction. In his prior executive roles, Patricio focused on scaling operations, driving quality and operational excellence, and building world-class teams.
'I am honored to join VIVEbiotech at such a pivotal point in its evolution. I firmly believe that VIVE's unique value proposition is redefining the standards by which CDMOs address customer needs and drive meaningful advancements that improve lives.' said Mr. Massera. 'I look forward to working closely with the Board and the leadership team to enhance operational robustness, expand capabilities, and strengthen the strategic partnerships that define VIVE's commitment to customer success.'
Mr. Massera joins VIVEbiotech's leadership team alongside Chairperson Dr. Stefan Beyer—a seasoned CDMO executive and former CEO of Vibalogics—and CEO Jon Alberdi, who has led the company's emergence as a global leader in lentiviral vector manufacturing.
'Patricio brings a unique combination of strategic vision, technical expertise, and operational excellence,' said Dr. Stefan Beyer, Chairperson of VIVEbiotech. 'He has consistently demonstrated a strong ability to scale organizations while upholding excellence in quality and customer service. The Board is confident in his ability to help lead VIVEbiotech into its next phase of growth. We are delighted to welcome him and look forward to working closely together.'
Jon Alberdi, CEO, VIVEbiotech added, 'Patricio's deep industry knowledge and leadership skills are a perfect fit for our ambitious goals. I look forward to working together to deliver exceptional value to our clients and to further strengthen our position as a leading CDMO.'
VIVEbiotech is one of the few CDMOs globally with deep expertise in both ex vivo and in vivo lentiviral vector development and manufacturing. Its fully integrated service offering supports therapies across a range of indications, including oncology (CAR-T, NK), autoimmune diseases, and vaccines. VIVE serves established global pharmaceutical leaders as well as emerging, innovative start-ups, with a customer base spanning Europe, the U.S., and Australia.
About VIVEbiotechVIVEbiotech is a Contract Development and Manufacturing Organization (CDMO) specializing in lentiviral vectors for gene and cell therapy. Founded in 2015, VIVEbiotech operates under EMA and FDA standards, serving over 40 biotech companies globally. The company focuses on scalable, high-yield manufacturing processes and cutting-edge technologies. With expertise in both ex vivo and in vivo applications, VIVEbiotech supports the development and commercialization of therapies for cancers and rare diseases. For more information about VIVEbiotech, please visit vivebiotech.com.
About Ampersand Capital PartnersAmpersand Capital Partners, founded in 1988, is a middle-market private equity firm with $3 billion of assets under management, dedicated to growth-oriented investments in the healthcare sector. With offices in Boston, MA, and Amsterdam, Netherlands, Ampersand leverages a unique blend of private equity and operating experience to build value and drive long-term performance alongside its portfolio company management teams. Ampersand has helped build numerous market-leading companies across each of the firm's core healthcare sectors. For additional information, visit AmpersandCapital.com or follow us on LinkedIn.
Attachments
VIVEbiotech
Patricio Massera
CONTACT: Naiara Tejados, PhD VIVEbiotech T +34 943 308 568 – Ext. 244 ntejados@vivebiotech.comSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
30 minutes ago
- Forbes
FC Barcelona To Receive This Offer From European Giant For Ter Stegen
FC Barcelona is set to receive an offer from a European giant - and that which knocked it out of the ... More Champions League last season - for Marc-Andre ter Stegen according to SPORT, which cited anonymous sources. FC Barcelona is set to receive an offer from a European giant - and that which knocked it out of the Champions League last season - for Marc-Andre ter Stegen according to SPORT, which cited anonymous sources. Though he started 2024/2025 as his team's captain and number one shotstopper, a pretty much campaign-ending injury knocked the German down the pecking order in Catalonia. Wojciech Szczesny was brought out of retirement to cover for the skipper and did a pretty outstanding job as Barca won all three titles on offer in Spain. After Barca shipped seven goals to Inter Milan, however, which saw them lose 7-6 on aggregate in the UCL finals, the quest for a new goalkeeper began. Barca didn't cast its net far and simply looked across the city to Espanyol. Activating breakout star Joan Garcia's $29.5 million (€25 million) and swiftly announcing the 24-year-old. Ter Stegen has since been the subject of endless reports with regards to being forced out of the club. While Sporting Director Deco said that he doesn't owe the veteran an explanation, he will reportedly have talks to clear up his future with head coach Hansi Flick before preseason training starts on July 13. Before that, though, Ter Stegen could have already been shipped off to another club. There has already been interest in him from Saudi Arabia and Galatasaray, but it is Inter Milan that is now thinking of lodging an offer in the coming days. Galatasaray has reportedly switched its focus to the Italians' goalkeeper Yan Sommer, who has just one year left on his contract at the San Siro, and that has forced the UCL runners-up recently knocked out of the Club World Cup by Fluminense to look for a replacement. Ter Stegen went from 'untouchable' to surplus to requirements at FC Barcelona Whether he moves on in the near future or sees out his contract which runs until 2028, Ter Stegen has gone from an 'untouchable' captain at FC Barcelona to a figure that is surplus to requirements while having become angered as what he perceives to be a media campaign against him aimed at forcing his exit.
Yahoo
39 minutes ago
- Yahoo
Equipment manufacturer turns heads with next-gen work vehicles boasting incredible performance: 'It is an ideal tool'
In a huge move for the industrial and construction industries, Spanish equipment manufacturer AUSA has introduced its first-ever electric rough-terrain forklift, per Electrek. Unveiled at the recent Bauma construction fair in Germany, the C151E is designed to bring the well-known benefits of electric vehicles into demanding job sites and represents a significant innovation in heavy‑duty material handling. AUSA shared in a video all the specs of the C151E, including a 3,000-pound loading capacity, battery with up to 18.6 kilowatt-hours, digital display with diagnostics, all-in-one joystick, zero carbon pollution, and it's nearly silent. AUSA said in a press release that the forklift is designed specifically for worksites with low pollution, like greenhouses and enclosed spaces. Electrek reported that the forklift also charges incredibly quickly: "Even if you drive the battery to nearly nothing, the AUSA can be charged up during a lunch break or shift change and ready to work again as soon as you reach for it." There is a growing trend of electrifying necessary equipment in manufacturing industries. Another European Union company announced an all-new electric line of construction equipment in 2024. Australia and China are also seeing similar innovations. Forklifts are indispensable across countless sectors, from agriculture and recycling to logistics and construction. Introducing electric models such as the C151E means smoother, more efficient operations and a great way to cut costs. "It is an ideal tool for working in emission-free spaces such as greenhouses, municipal night works, enclosed spaces, etc.," AUSA said, according to Electrek. Companies can expand their use, because electric assets are allowed where internal combustion isn't. "You can earn more work, get a higher utilization rate, and maximize not only your fuel savings, but generate income you couldn't generate without it," Electrek explained. Beyond financial savings, without tailpipe pollution, the forklift is also beneficial to the environment as well as the health of those operating it. Traditional diesel and gas-powered forklifts can negatively impact air quality and worker health, especially in enclosed spaces like warehouses, because of the release of carbon monoxide as well as known carcinogens. Thanks to innovations like the C151E, it's now easier than ever for companies to cut costs, protect worker health, and get the job done — without all the noise and fumes. It's a win for business and a win for the environment. If you're thinking about switching to electric yard tools, which of these factors would be most persuasive for you? Better for the environment Cheaper to fuel and maintain More enjoyable to use Produce better results Click your choice to see results and speak your mind. Join our free newsletter for weekly updates on the latest innovations improving our lives and shaping our future, and don't miss this cool list of easy ways to help yourself while helping the planet.
Yahoo
an hour ago
- Yahoo
Suze Orman: This Asset Continues To Grow Whether You Want It To or Not — Should You Invest?
Suze Orman thinks that energy stocks will grow in the next two years — but don't invest in them just yet. In her recent podcast episode, 'Suze School: Savings vs. Consumption', the financial advisor, author and podcast host emphasizes to listeners the high demand for oil. Trending Now: Read Next: 'The demand for oil, whether you want it to or not, continues to grow and that's because there are more emerging economies that are out there, and they are increasingly demanding the use of oil,' said Orman. GOBankingRates breaks down why the money expert wants investors to pay attention to this asset. Orman doesn't think the 'green dream' as she calls it, will become a reality as wind and solar are not stable. She suggests this was seen in the recent blackouts in Spain and Europe. However, as Nasdaq reports, the U.S. is expected to see great demand for electric power from AI-driven data center growth, wider adoption of electric vehicles and an increase in residential usage. Discover More: Orman predicts over the next two years, oil will be about $150 a barrel or higher, which is higher than the $130 a barrel during the Russian invasion of Ukraine in March 2022. Recently, it was $55 per barrel, the expert points out. 'There will come a day where you want to invest again in energy stocks and I think that will be in around 2026, so just be patient there,' Orman said. With only 22 companies, energy is one of the most concentrated Global Industry Classification Standard sectors in the stock market. More From GOBankingRates The New Retirement Problem Boomers Are Facing This article originally appeared on Suze Orman: This Asset Continues To Grow Whether You Want It To or Not — Should You Invest?
